Stryker Total Assets 2006-2018 | SYK

Stryker total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Stryker total assets for the quarter ending December 31, 2018 were $27.229B, a 22.67% increase year-over-year.
  • Stryker total assets for 2018 were $27.229B, a 22.67% increase from 2017.
  • Stryker total assets for 2017 were $22.197B, a 8.62% increase from 2016.
  • Stryker total assets for 2016 were $20.435B, a 25.96% increase from 2015.
Stryker Annual Total Assets
(Millions of US $)
2018 $27,229
2017 $22,197
2016 $20,435
2015 $16,223
2014 $17,279
2013 $15,743
2012 $13,206
2011 $12,146
2010 $10,895
2009 $9,071
2008 $7,603
2007 $7,354
2006 $5,874
2005 $4,993
Stryker Quarterly Total Assets
(Millions of US $)
Q4 2018 $27,229
Q3 2018 $22,084
Q2 2018 $21,570
Q1 2018 $22,133
Q4 2017 $22,197
Q3 2017 $21,485
Q2 2017 $21,292
Q1 2017 $20,517
Q4 2016 $20,435
Q3 2016 $20,187
Q2 2016 $20,520
Q1 2016 $19,668
Q4 2015 $16,223
Q3 2015 $15,917
Q2 2015 $16,819
Q1 2015 $16,580
Q4 2014 $17,279
Q3 2014 $17,515
Q2 2014 $17,229
Q1 2014 $16,159
Q4 2013 $15,743
Q3 2013 $14,883
Q2 2013 $14,382
Q1 2013 $14,089
Q4 2012 $13,206
Q3 2012 $12,777
Q2 2012 $12,262
Q1 2012 $12,459
Q4 2011 $12,146
Q3 2011 $12,083
Q2 2011 $11,596
Q1 2011 $11,231
Q4 2010 $10,895
Q3 2010 $10,772
Q2 2010 $10,060
Q1 2010 $10,098
Q4 2009 $9,071
Q3 2009 $8,459
Q2 2009 $7,924
Q1 2009 $7,585
Q4 2008 $7,603
Q3 2008 $7,575
Q2 2008 $8,025
Q1 2008 $7,754
Q4 2007 $7,354
Q3 2007 $6,859
Q2 2007 $6,420
Q1 2007 $6,077
Q4 2006 $5,874
Q3 2006 $5,399
Q2 2006 $5,109
Q1 2006 $4,994
Q4 2005 $4,993
Q3 2005 $4,397
Q2 2005 $4,168
Q1 2005 $4,068
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $69.625B $13.601B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.164B 26.13
Medtronic (MDT) Ireland $123.923B 18.53
Boston Scientific (BSX) United States $55.366B 27.03
Baxter (BAX) United States $39.075B 24.08
Zimmer Biomet Holdings (ZBH) United States $25.222B 16.18
Smith & Nephew SNATS (SNN) United Kingdom $16.659B 0.00
ResMed (RMD) United States $14.394B 27.30
Canopy Growth (CGC) Canada $11.042B 0.00
Bio-Rad Laboratories (BIO) United States $8.100B 51.79
Aurora Cannabis (ACB) Canada $7.040B 50.36
Hill-Rom Holdings (HRC) United States $6.974B 21.57
Perrigo (PRGO) Ireland $6.650B 10.09
Insulet (PODD) United States $5.226B 0.00
ICU Medical (ICUI) United States $5.189B 28.91
GW Pharmaceuticals (GWPH) United Kingdom $4.539B 0.00
Haemonetics (HAE) United States $4.489B 39.82
Agios Pharmaceuticals (AGIO) United States $3.449B 0.00
Hutchison China MediTech (HCM) China $3.417B 0.00
Neogen (NEOG) United States $3.281B 50.39
NuVasive (NUVA) United States $3.013B 28.03
National Vision Holdings (EYE) United States $2.624B 50.75
Quidel (QDEL) United States $2.574B 23.28
Aphria (APHA) $2.402B 106.67
NxStage Medical (NXTM) United States $1.954B 0.00
AtriCure (ATRC) United States $1.279B 0.00
Phibro Animal Health (PAHC) United States $1.231B 17.70
VAREX IMAGING (VREX) United States $1.198B 23.45
Cardiovascular Systems (CSII) United States $1.170B 840.00
HEXO (HEXO) $1.156B 0.00
MacroGenics (MGNX) United States $0.923B 0.00
Cerus (CERS) United States $0.878B 0.00
PetIQ (PETQ) United States $0.837B 21.68
Surmodics (SRDX) United States $0.766B 111.39
Evolus (EOLS) United States $0.747B 0.00
NanoString Technologies (NSTG) United States $0.719B 0.00
Lantheus Holdings (LNTH) United States $0.713B 22.07
Meridian Bioscience (VIVO) United States $0.704B 20.97
OraSure Technologies (OSUR) United States $0.703B 31.03
Omeros (OMER) United States $0.688B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.625B 20.05
Quanterix (QTRX) United States $0.505B 0.00
LeMaitre Vascular (LMAT) United States $0.492B 24.18
Owens & Minor (OMI) United States $0.479B 5.42
TG Therapeutics (TGTX) United States $0.395B 0.00
Insys Therapeutics (INSY) United States $0.368B 0.00
Utah Medical Products (UTMD) United States $0.334B 21.65
BioLife Solutions (BLFS) United States $0.299B 404.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.293B 0.00
Bovie Medical (APYX) United States $0.279B 0.00
Vapotherm (VAPO) United States $0.276B 0.00
Cytosorbents (CTSO) United States $0.262B 0.00
Rockwell Medical (RMTI) United States $0.242B 0.00
Zynex (ZYXI) United States $0.165B 15.97
Surface Oncology (SURF) United States $0.150B 0.00
Fonar (FONR) United States $0.143B 7.65
Chembio Diagnostics (CEMI) United States $0.119B 0.00
Chimerix (CMRX) United States $0.101B 0.00
United-Guardian (UG) United States $0.091B 18.98
Female Health (VERU) United States $0.084B 0.00
InfuSystems Holdings (INFU) United States $0.081B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.33
Conatus Pharmaceuticals (CNAT) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Myomo (MYO) United States $0.016B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 13.57